Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06414109 · ClinicalTrials.gov registry record · NA

Mindfulness-Based Intervention for Adolescents With Chronic Migraine

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT06414109: Completed NA study, sponsored by University of Colorado, Denver.

NCT06414109 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06414109, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

The goal of this study is to assess feasibility and acceptability of a mindfulness-based intervention adapted for adolescents with migraine to inform a future randomized trial assessing effects of the intervention on headache-related outcomes.

Primary Outcome

Percent of sessions attended; Qualitative data generated via focus group interviews (questions will include barriers and facilitators to completing the intervention)

Interventions

  • BEHAVIORAL BREATHE-Migraine

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2024-06-04
Est. Completion 2025-05-23
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT06414109 record still lists

NCT06414109 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which BREATHE-Migraine is the first listed.

NCT06414109 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06414109 about?

NCT06414109 is a clinical study titled "Mindfulness-Based Intervention for Adolescents With Chronic Migraine". The goal of this study is to assess feasibility and acceptability of a mindfulness-based intervention adapted for adolescents with migraine to inform a future randomized trial assessing effects of the intervention on headache-related outcomes.

What is the current status of trial NCT06414109?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2024-06-04. Estimated completion is 2025-05-23.

What interventions are being tested in trial NCT06414109?

The interventions under investigation include: BREATHE-Migraine (BEHAVIORAL).

Who is sponsoring clinical trial NCT06414109?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06414109's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06414109, the US trial registry maintained by the National Library of Medicine. NCT06414109 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.